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Abstract
Background: Bacterial gastroenteritis causes morbidity and mortality in humans worldwide. Murine Citrobacter rodentium
infection is a model for gastroenteritis caused by the human pathogens enteropathogenic Escherichia coli and
enterohaemorrhagic E. coli. Mucin glycoproteins are the main component of the first barrier that bacteria encounter in the
intestinal tract.
Methodology/Principal Findings: Using Immunohistochemistry, we investigated intestinal expression of mucins (Alcian
blue/PAS, Muc1, Muc2, Muc4, Muc5AC, Muc13 and Muc3/17) in healthy and C. rodentium infected mice. The majority of the
C. rodentium infected mice developed systemic infection and colitis in the mid and distal colon by day 12. C. rodentium
bound to the major secreted mucin, Muc2, in vitro, and high numbers of bacteria were found in secreted MUC2 in infected
animals in vivo, indicating that mucins may limit bacterial access to the epithelial surface. In the small intestine, caecum and
proximal colon, the mucin expression was similar in infected and non-infected animals. In the distal colonic epithelium, all
secreted and cell surface mucins decreased with the exception of the Muc1 cell surface mucin which increased after
infection (p,0.05). Similarly, during human infection Salmonella St Paul, Campylobacter jejuni and Clostridium difficile
induced MUC1 in the colon.
Conclusion: Major changes in both the cell-surface and secreted mucins occur in response to intestinal infection.
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Introduction
Bacteria such as enteropathogenic Escherichia coli (EPEC),
enterohaemorrhagic E. coli (EHEC), Salmonella enteritidis and
Clostridium difficile are major causes of infectious diarrhea in
humans worldwide. EPEC and EHEC develop a commensal,
rather than pathogenic, interaction within the mouse host [1,2]. C.
rodentium is a natural mouse pathogen that is related to, and uses
the same molecular mechanisms of type III secretion and
attaching and effacing lesions as human EPEC and EHEC, to
colonise the epithelial cells of the gut, hence providing a good in
vivo model for gastroenteritis due to these bacteria [3,4].
The gastrointestinal tract is lined by a continuously secreted
mucus layer formed by high molecular mass oligomeric mucin
glycoproteins. This mucus layer moves to clear trapped material.
In the healthy human intestine, MUC2 is the main secreted mucin
making up the mucus layer, whereas in the stomach MUC5AC
and MUC6 are produced. Under the mucus layer, the cell-surface
mucins are a dominant feature of the apical surface of all mucosal
epithelial cells. Cell-surface mucins are likely to play an important
role in mucosal defense since they may provide both a barrier and
reporting function, and we have demonstrated increased pathol-
ogy following gastrointestinal infection in mice lacking the Muc1
cell surface mucin [5,6]. These filamentous molecules extend
further than most other cell surface structures [7]. The intestine
produces the MUC1, MUC3, MUC4 MUC12, MUC13 and
MUC17 cell surface mucins [8,9].
Microbial products and inflammatory cytokines stimulate
increased production of mucins by mucosal epithelial cells, which
can effect a massive discharge of mucin in response to stimuli
[10,11,12,13,14,15,16,17,18,19,20,21]. Stimulated mucin release
occurs rapidly and is accompanied by a hundredfold expansion of
the secretory granules upon hydration. Several pathogens have
been shown to interact with mucins [22,23,24,25,26], including
EPEC and EHEC which bind to bovine mucins [27]. Upregula-
tion of MUC3 expression in colonic cells has been correlated with
decreased binding of EPEC [28,29]. The ability of human milk to
limit gastrointestinal bacterial and viral infections has been
attributed in part to the presence of large amounts of cell surface
mucins, chiefly MUC1 and MUC15 [30,31,32]. Consistent with
an important role for Muc1 upregulation in the intestine limiting
infection, Muc1
2/2 mice have a higher rate of systemic infection
in a murine Campylobacter jejuni model of gastroenteritis [6]. Many
pathogens have evolved mechanisms to subvert the mucin barrier,
for example the StcE zinc metalloprotease secreted by EHEC is a
mucinase [33].
Goblet cell depletion in infection has been reported previously
[34], however, no comprehensive study of expression of all mucins
in an animal infection model has been performed. We map the
localization along the intestinal tract of all murine mucins for
which antibodies are available: Muc1, Muc2, Muc4, Muc5AC,
Muc13 and Muc3 (orthologue of human MUC17, therefore
hereafter referred to as Muc17. There is currently no Muc3
orthologue annotated in the mouse genome. However, a peptide
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identified using proteomics on mouse mucins, suggesting the
presence of the mouse orthologue to this mucin [35]). In a murine
C. rodentium infection model, we demonstrate substantial changes in
the amount of virtually all intestinal mucins after 12 days of
infection. We further showed mucin binding to C. rodentium,
demonstrating that the release of mucins has the capacity to
remove bacteria from the epithelial surface.
Materials and Methods
Animals
8–16 weeks old male129/SvJxC57BL/6 mice were housed
under clean conventional conditions, and allowed free access to
sterilized food and water. All experiments were approved by the
University of Queensland Animal Experimentation Ethics Com-
mittee (approval no 059/07). Colonies routinely tested negative for
murine viral and bacterial pathogens.
Infection of mice
Citrobactum rodentium strain ICC169 was grown on Lauria-
Bertani agar for 20 h at 37uC. Bacteria harvested from plate
cultures were suspended in warmed Lauria-Bertani broth. 8 mice
were orally inoculated with 10
7 colony forming units (CFU) and
sacrificed after 12 days by cervical dislocation. Duplicate samples
of duodenum, caecum, small intestine and proximal, mid and
distal colon were dissected and collected in either broth or 10%
formalin. To assess the number of CFU/g tissue, tissue and fecal
samples (collected as defecated samples) were homogenized in
broth, serially diluted, plated onto McConkey’s selective agar, and
grown for 20 h at 37uC. CFU were enumerated by counting C.
rodentium ,1 mm diameter fuschia-coloured colonies. The mice
were weighed and diarrhea was scored every second day.
Histological assessment
For analysis of colitis, formalin fixed tissue sections of the small
intestine, caecum, proximal and distal colon stained with
hematoxylin/eosin were coded to blind the analysis, and the
entire section was systematically scored: aberrant crypt architec-
ture (0–5), increased crypt length (0–3), goblet cell depletion (0–3),
general leukocyte infiltration (0–3), lamina propria neutrophil
counts (0–3), crypt abscesses (0–3), and epithelial damage and
ulceration (0–3) were scored (full details in Table S1).
Human biopsies
Individuals with acute diarrhoea are not usually subjected to
colonoscopic examination and biopsy, but archival biopsy material
was available from seven patients with acute gastroenteritis. These
patients included four previously healthy individuals and three
patients with underlying inflammatory bowel disease, as described in
Table 1. For controls, biopsies were examined from the same IBD
patients when there was no detectable bacterial infection or from the
samedistalcolonicsitefromageand sexmatched healthyindividuals
(Table 1). The archived biopsies were collected and treated in
accordance with the Australian National Statement on Ethical
Conduct in Human Research (2007) (http://www.nhmrc.gov.au/
publications/synopses/e72syn.htm) guidelines for archived patho-
logical material. There is no consent process required for this type of
use. The biopsies were collected between 1/06 and 1/08 for
diagnostic histopathology as requested by the attending doctor. The
samples were processed by the Mater Health Services Pathology
Service as requested by the attending doctor. The paraffinblocks are
kept on level 6 of the Mater Adult Hospital, which is where the
Mater Health Services Pathology Service is housed.
Antibodies
The MUC1 antibody (CT2[36]) and the Muc17/Muc3-S2
antibody (raised against the peptide KYTPGFENTLDTVVKN-
LETKIKNAT [35] were kind gifts from Prof. S. Gendler,
Scottsdale, USA, and Prof. G. Hansson, Gothenburg, Sweden.
The polyclonal anti sera against the C-terminal sequence of
MUC4 (hHA1-B-1) was a kind gift from Prof. K. Carraway,
Miami, USA. The MUC5AC antibody (45MI) was purchased
from Sigma [37]. Polyclonal antisera (rM13.C and MM2-2)
against the cytoplasmic tail of the human MUC13 and murine
Muc2 was raised in rabbit using bovine serum albumin conjugated
peptides CMQNPYSRHSSMPRPDY and CPEDRPIY-
DEDLKK, respectively [38,39], and then purified on a HiTrap
NHS-activated HP column (Amersham Biosciences, Uppsala,
Sweden) coupled to the same peptides according to manufacturers
instructions. The monospecificity of the CT2 and rM13.C
antibodies were demonstrated by that gastric and intestinal
specimens from Muc1 and Muc13 knockout mice were negative
for staining with the respective antibodies. The staining pattern of
the hHA1-B-1 antisera was similar to that previously described for
MUC4 in human tissue [40,41], and the pre-immune sera from
the hHA1-B-1 rabbit did not stain any tissue. The 45M1 antibody
recognizes MUC5AC (and no other molecules in gastric tissue
extracts) in human and rhesus monkey as demonstrated by that
only fractions from density gradient centrifugation that has a
density appropriate for MUC5AC (1.4 g/ml) are recognized with
this antibody [37], and the mouse gastric tissue used here as a
positive control demonstrated a strong surface epithelial cell
staining, similar to that of the human and rhesus monkey gastric
tissue[37], whereas the intestinal tissue was negative. Similarly, the
MM2-2 antibody recognize material from intestinal tissue extracts
in fractions of appropriate density from density gradient
centrifugation of MUC2/Muc2, show a distinct goblet cell staining
pattern in the intestine of mice similar to that demonstrated in
human [39], and did not stain the gastric negative control tissue.
The specificity of the Muc3-S2 antibody has been confirmed using
mass spectrometry [35].
Immunohistochemistry
Mouse samples: Formalin-fixed, paraffin-embedded tissue
sections (4 mm) of archived biopsies from mouse stomach,
duodenum, caecum, small intestine and proximal-, mid- and
distal colon were dewaxed and rehydrated. Antigen retrieval used
Table 1. Human biopsies used for investigating MUC1
induction in infectious colitis.
Infection patient Control patient
Infectious
agent
Age Sex IBD status*
59 F No Different patient: matched for age,
sex and biopsy site
S. St Paul
71 F C. jejuni
23 F C. jejuni
46 M C. jejuni
19 M CD Same patient and biopsy site.12
months from acute infection
C. difficile
47 F CD C. difficile
27 M UC S. enteritidis
*CD=Crohn’s disease, UC=ulcerative colitis.
doi:10.1371/journal.pone.0003952.t001
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citric acid, pH 6 at 95uC for 20 min (CT2, Muc17/Muc3-S2); 2)
10 mM citric acid, pH 6 at 95uC for 20 min followed by 10 mM
1,4-dithiothretiol in 0.1 M Tris/HCl buffer, pH 8 at 37uC for
30 min and then 25 mM iodoacetamine in the dark for 30 min
(MM2-2); 3) High pH Antigen Retrieval Solution (Dako, RC20);
or 4) Rodent decloaker (Biocare Medical, 45M1) at 80uC for 2 h.
Sections were then treated with 3% (v/v) hydrogen peroxide for
10 min at room temperature. The sections were washed 3 times
between all subsequent steps in phosphate buffered saline, pH 7.4
(PBS) containing 0.05% Tween-20. Non-specific binding was
blocked by 10% Milk Diluent/Blocking solution (KPL, Maryland,
USA) in PBS (CT2, MM2-2, Muc3-S2, hHAI-B-1 and RC20) or
rodent block M (Biocare Medical, 45M1) for 30 min. The sections
were incubated with a primary antibody diluted in 10% Milk
Diluent/Blocking solution (KPL, Maryland, USA) in PBS
containing 0.05% Tween-20 (CT2 1:50, MM2-2 5 mg/ml,
Muc17/Muc3-S2 1:2000, hHAI-B-1 1:200, 45M1 1:1000 and
rM13.C 30 mg/ml,) for 1 h, then incubated with anti-rabbit
antibody conjugated to horseradish peroxidise (HRP), MM2-2,
Figure 1. C. rodentium induced colitis and infection load. The number of C. rodentium CFU in feces increased over time (A, * p,0.05 compared
to pre-inoculation,
# p,0.05 compared to day 7, Mann Whitney U test, n=8). At day 12, a higher number of CFU was detected in the large intestine
(LI) than in the small intestine (SI) (B,* p,0.05), and low numbers of CFU were found in the internal organs (C). Histological colitis scores were low to
moderate, with the distal large intestine being worst affected (D).
doi:10.1371/journal.pone.0003952.g001
Figure 2. Serum Ig response to C. rodentium. Serum concentra-
tions of Ig reactive with C. rodentium lysate determined by ELISA in 8
mice prior to and 1, 7 and 12 days following infection.
doi:10.1371/journal.pone.0003952.g002
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streptavidin-HRP (CT2) for 1 h or with MM HRP-Polymer
(Biocare Medical, 45M1) for 20 min. Bound antibody was
visualized with diaminobenzidine for 10 min. The sections were
counterstained with Harris’s haematoxylin. Gastric sections were
used as positive controls for CT2 and 45M1. Human samples:
Formalin-fixed, paraffin-embedded tissue sections (4 mm) of
archived biopsies were dewaxed and rehydrated. Sections were
treated with 1% periodic acid to expose the epitope and then with
3% (v/v) hydrogen peroxide for 30 min at room temperature. The
sections were washed 3 times between all subsequent steps in
0.15 M NaCl, 0.1 M Tris/HCl buffer (pH 7.4) containing 0.05%
Tween-20. Non-specific binding was blocked by protein block
(Dako) for 30 min. The sections were incubated with the BC2
antibody diluted in Antibody Diluent for 1 h, then incubated with
Broad Spectrum Poly HRP Conjugate (Zymed Laboratories inc,
San Fransisco, USA) for 10 min and then with diaminobenzidine
for 10 min. The sections were counterstained with Harris’s
haematoxylin.
Staining was classified into one of four categories: high level of
staining (approx. 90–100% of cells staining, score=3), medium
level of staining (25–90%, score=2), low level of staining (1–25%,
score=1) and virtually no staining (,1%, score=0). The scoring
of the stain was performed by an individual blinded to the
infection status of the mice. Two of the stains were also analyzed
by a second individual blinded to the infection status of the
animals, and the results between the two scorers were consistent.
PAS/Alcian blue stain
De-waxed sections were immersed in 100% ethanol for 10 min,
rinsed in water for 10 min, immersed in 3% acetic acid for 2 min
and stained in 1% Alcian Blue 8GX in 3% acetic acid (pH 2.5) for
2.5 h. Non specific stain was removed with 3% acetic acid and
rinsed in water for 10 min. The slides were then oxidized in 1%
periodic acid in water at room temperature for 10 min, washed in
water for 5 min, immersed in Schiff’s reagent for 10 min, rinsed in
water for 5 min and then three times in 0.5% sodium meta-
bisulphite before a final wash in water. To reveal O-acetylated
oligosaccharides sections were first treated with 0.1 M KOH for
30 min and then 1 mM periodic acid prior to the Schiff reagent.
Antibody response against C. rodentium
C. rodentium were harvested into PBS, washed once and then
sonicated 5 times while on ice with a 3 min interval between
sonications. After sonication, the solution was centrifuged at
4000 g for 4 min. The supernatant was diluted to A280=0.4 and
plated onto Maxisorb plates (Nunc). The microtiter plates were
washed 3 times in PBS pH 7.4 containing 0.05% Tween-20
between all ensuing steps. Unbound sites were blocked with 1%
bovine serum albumin (BSA) for 1 h. The microtiter plates were
incubated with murine sera diluted 1:100 in PBS containing 1%
BSA and 0.05% Tween, pH 7.4, for 1 h at room temperature.
The microtiter plates were incubated with HRP conjugated anti
mouse Ig diluted 1:2000. Bound secondary antibody was
visualized using BD OptEIA TMB substrate reagent (BD, San
Diego, USA). The reaction was stopped with 1 M sulphuric acid
and absorbance at 450 nm was measured.
C. rodentium binding to Muc2
The insoluble complex of Muc2 was extracted from murine
intestinal mucosal scrapings as previously described [42]: mucosal
scrapings were gently dispersed with a Dounce homogenizer in
6 M guanidinium chloride, 5 mM EDTA, 5 mM N-ethylmalei-
mide, 10 mM sodium phosphate buffer, pH 7.0, and left stirring at
4uC overnight. After centrifugation (21,000 g, 4uC, 60 min), the
soluble material was removed, and the pellets were re-extracted
twice, as described above. The final extraction residues (insoluble
glycoprotein complex) were solubilized by reduction in 6 M
guanidinium chloride, 10 mM dithiothreitol, 5 mM EDTA,
0.1 M Tris-HCl buffer, pH 8.0, at 37uC overnight and then
alkylated with 25 mM iodoacetamide in the same buffer and then
dialyzed against 4 M guanidinium chloride. After centrifugation,
the supernatant was retained. This solubilised ‘‘insoluble’’ MUC2
complex was diluted in 4 M guanidinium chloride and 100 ml/
well were coated onto microtiter plates (NUNC F96; Polysorp,
Roskilde, Denmark) overnight at 4uC. The microtiter plates were
washed 3 times in PBS pH 7.4 containing 0.05% Tween-20
between all ensuing steps. Unbound sites were blocked with 0.5%
bovine serum albumin in 1% blocking reagent for ELISA in PBS
containing 0.05% Tween-20 for 1 h. The microtiter plates were
incubated with biotinylated C. rodentium in 1% in blocking reagent
for ELISA containing 0.05% Tween pH 7.4 for 1 h at room
temperature. The microtiter plates were incubated with HRP
conjugated streptavidin diluted 1:2000. Bound secondary antibody
was visualized using 2,29-azinobis(3-ethylbenzothiazoline)-6-sul-
phonic acid as a substrate in citric acid- Na2HPO4 buffer, pH 4.3.
Absorbance at 405 nm was measured after 40 min. When the 6 M
guanidinium HCl-insoluble fraction containing Muc2 was sub-
jected to agarose gel electrophoresis and then blotted onto a
membrane, the only PAS positive band present corresponded
exactly to the MU2 band identified by Western blotting. However,
we have not performed Western blotting for other mucins and
very small amounts of other contaminating mucins cannot be
excluded.
Statistics
CFU data were log transformed. Individual data points are
presented and the non-parametric Mann Whitney U test was
applied to ascertain differences. All statistics were determined
using Systat 12 (Systat Software, Inc., San Jose, USA).
Results
C. rodentium infection and associated pathology is
greatest in the large intestine
Before inoculation, C. rodentium was not detected in the murine
feces (Figure 1A). On day 7, C. rodentium was detected in feces of 5/
8 mice and the mean C. rodentium content in feces was 10
3 CFU/g.
By day 12, C. rodentium was detected in feces of 6/8 mice and the
mean C. rodentium content in feces had increased to 10
5 CFU/g
Figure 3. Tissue localization of mucins in small intestine and caecum. Histologically, the small intestinal villi and caecal crypts are covered by
a simple columnar epithelium consisting of enterocytes with interspersed goblet cells. Using immunohistochemistry, we demonstrated that the
apical surface of small intestine and caecal epithelia are lined by the cell surface mucins Muc13 and Muc17 as well as a small amount of Muc4
(brown). The goblet cells contain alcian blue positive material (blue), which mainly is Muc2 (brown), but also some Muc4. The photographs were
taken using a 206magnification. The quantification scores for any of these mucins were not significantly different between non-infected mice (#)
and mice infected with C. rodentium for 12 days (N) in these areas of the intestine. (Mann Whitney U test, n=7). SCL=subcellular localization,
RC=region of crypt. The mucin stains are shown in serial sections on the same tissue area, whereas the mucin stain scores represent the average
stain scores for the entire specimen for each individual mouse.
doi:10.1371/journal.pone.0003952.g003
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at 12 days and the fecal C. rodentium load decreased at later time
points (data not shown), we sacrificed the mice on day 12. C.
rodentium was detected in intestinal tissues of 7/8 mice with
approximately 100 fold higher CFU in the colon compared to
small intestine (10
8 vs 10
6, Figure 1B). In 6/8 animals C. rodentium
was detected in the liver and/or spleen, demonstrating that live
bacteria cross the intestinal barrier. The mice did not lose any
weight, and the infection only induced mild diarrhea with no
rectal bleeding at any time (data not shown).
In the small intestine, only 1/8 mice developed mild
inflammation with irregular crypt architecture, 10–25% goblet
cell loss, increased leukocytes in the lamina propria and slightly
increased levels of polymorphonuclear cells in the lamina propria.
In the caecum and proximal colon, 6/8 animals showed signs of
mild colitis (Figure 1D). The distal colon was most affected by the
infection with moderate crypt loss, crypt abscesses, discrete lesions,
increased crypt length, .50% goblet cell loss, transmural
extension of inflammatory infiltrates and high levels of polymor-
phonuclear cells in the lamina propria (Figure 1D). Non-infected
control mice did not show any signs of colitis (data not shown).
Mice infected with C. rodentium normally mount an IgG response
that eradicates the bacteria after 3–4 weeks [43]. By day 12 most
mice in this study had an increased Ig response to C. rodentium
(Figure 2). However, at this time point the Ig response had not
cleared the C. rodentium in any of the animals as all the animals with
an increase in C. rodentium reactive Ig had both high intestinal CFU
counts and C. rodentium present in their spleen and/or liver.
Mucin expression in the healthy murine intestinal tract
and following C. rodentium infection
Mucin expression was evaluated by Alcian blue/periodic acid
Schiff (AB/PAS) staining and by immunohistochemistry for the
Muc2 and Muc5AC secreted mucins, and the Muc1, Muc3/17
(hereto Muc17), Muc4 and Muc13 cell surface mucins in the small
intestine, caecum, proximal-, mid- and distal large intestine of
uninfected and infected mice. Muc5ac was not expressed in
normal or infected intestine (stomach control sections were
strongly positive).
Small Intestine. AB stains acidic mucins blue and the PAS
stains neutral mucins pink whilst mixtures of neutral and acidic
mucins appear purple. In the small intestine, the goblet cells varied
from purple to blue and tended to be bluer towards the bottom of
the crypts with more purple/fushia towards the top (Figure 3),
indicating that the carbohydrates are more highly charged towards
the bottom of the crypts. All goblet cells expressed Muc2 and most
of the villous goblet cells expressed Muc4 with weaker staining in
the crypt goblet cells. Enterocytes expressed the Muc4, Muc13 and
Muc17 mucins, but not Muc1, with the Muc13 antibody giving
the strongest stain, which decorated the surface of the entire
glandular and villous epithelium. The presence of Muc4 in goblet
cells and enterocytes is similar to that described for human tissue,
and is consistent with previously published work showing that
MUC4 can be produced both in membrane bound and soluble
forms [40,41]. No discernable changes were seen in expression of
any of the mucins in the infected small intestine, despite the
presence of a low density of C. rodentium.
Caecum. Caecal goblet cells were strongly AB positive and
contained Muc2 and Muc4 (Figure 3). Muc4 was weakly expressed
on the epithelial surface, whereas Muc13 was strongly expressed
on the apical surface and in the cytoplasm of caecal epithelial cells
and Muc17 was apically expressed on the surface cells but not in
the crypts. Like the small intestine, Muc1 was not expressed in the
caecum and there were no changes in mucin expression in
response to infection.
Proximal large intestine. In the proximal large intestine the
two distinct crypt and surface lineages of goblet cells were both
strongly AB positive and contained Muc2, whereas Muc4 was
present in the goblet cells on the surface, but to a lesser degree in the
crypts (Figure 4). The enterocytesand their apical surfaces were both
weakly positive for Muc4 and more strongly positive for Muc13,
whereas Muc17 was restricted to the apical surface of the surface
epithelium, and Muc1 was not expressed (Figure 4). Although no
statistically significant differences in mucin expression were detected
between non-infected and C. rodentium infected proximal colon, the
Muc2/AB filled goblet cell thecae had a higher variability in size in
the infected animals with groups of crypts being either hypertrophic
and bulging, whilst other groups of crypts were partially depleted of
mucin (Figure 4). This suggests that both Muc2 production and
secretion is increased in the proximal large intestine of infected mice.
Saponification prior to mild PAS staining to reveal O-acetylated
mucin oligosaccharides revealed O-acetylation ina proportion of the
goblet cell lineage found at the base of the crypts of the proximal and
mid-colon, as previously reported [44]. Post-infection the loss of
goblet cells was reflected in reduced overall mild PAS staining,
however, in the remaining cells of the basal goblet cell lineage there
was an increase in mild PAS staining without prior saponification,
indicating a reduction of O-acetylation in those cells following
infection (Figure S1).
Mid and distal large intestine. In the mid and distal large
intestine, the upper half of the crypts contain the majority of the
goblet cells, whereas the lower half of the crypts contain cells of
secretory type but with a more vacuolated morphology [45]. AB/
PAS staining of the goblet cells revealed medium charged
carbohydrates from the middle of the crypt to the top, whereas
the bottom of the crypts had a small amount of highly charged
carbohydrate chains (Figures 5 and 6). As for the other regions of
the intestine these goblet cells expressed Muc2 and to a lesser
extent Muc4. In the mid- and distal colon, the apical surface of the
lower half of the crypt was weakly positive for Muc1 (Figures 5–6
and Figure S2, intensity score 0–0.5). Muc13 and Muc17 were
highly expressed in the cytoplasm of the cells with secretory
vacuolated morphology in lower half of the crypt and also
expressed on the apical surface of cells in the crypts and the surface
epithelium (Figure 6). Muc17 was also present cytoplasmically in
the bottom half of the crypt (Figures 5–6). Thus, the tissue
localization of Muc17 is similar to that of Muc13 in the mid and
distal large intestine, whereas differences occur in the more
proximal parts of the intestine.
C. rodentium caused focal damage and elongation of crypts in the
mid and distal colon, with patches of almost normal epithelium
Figure 4. Tissue localization of mucins in the proximal large intestine. The apical surface of the epithelial cells of the crypts in the leaf-like
folds of the proximal large intestine is lined by the cell surface mucins Muc4, Muc13 and Muc17 (brown). The goblet cells contain Alcian blue positive
material (blue), which mainly is Muc2 (brown), although the goblet cells of the surface also contain Muc4. The photographs were taken using a 206
magnification. The quantification scores for any of these mucins were not significantly different between non-infected mice (#) and mice infected
with C. rodentium for 12 days (N) in these areas of the intestine. (Mann Whitney U test, n=7). SCL=subcellular localization, RC=region of crypt. The
mucin stains are shown in serial sections on the same tissue area, whereas the mucin stain scores represent the average stain scores for the entire
specimen for each individual mouse.
doi:10.1371/journal.pone.0003952.g004
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animals, the distal colonic crypts were depleted of AB, Muc2 and
Muc4 positive material (p,0.05 for AB/PAS, Figure 6). In some
areas the goblet cell thecae were depleted from the base of crypts
but some goblet cell thecae remained at the top of crypts, and
there was a massive amount of secreted mucus and shed goblet
cells (see arrow in Figure 5) in the lumen. The mid large intestine
also tended to be depleted of stored Alcian blue positive material at
the bottom of the crypt and partially of the purple goblets from
mid length to top (Figure 6), although the variability between
animals was larger in this location. The more elongated crypts
tended to be more depleted of mucins linking goblet cell depletion
with localized infection and/or inflammation.
In the C. rodentium infected animals the apical Muc1 expression
in the lower half of the crypt was increased in the mid and distal
colon, and de novo expression occurred apically on the surface
epithelium in 3/4 animals (p,0.05, Figures 5–6 and Supplemen-
tary Figure 1). Although the apical Muc13 expression was similar
to that of non-infected animals, the cytoplasmic expression was
significantly decreased (Figures 5–6), consistent with increased
apical turn-over of this cell surface mucin. Similarly, Muc17 levels
in the cytoplasm of the crypt base also decreased in the mid and
distal large intestine with infection and the apical expression in the
surface epithelium also decreased (Figures 5–6).
C. rodentium binding to Muc2
In the healthy intestine, Muc2 is the main secreted mucin
composing the mucus layer, which is continuously washing the
intestinal surface to clear trapped material. Using a microtiter
based assay, we demonstrated that murine Muc2 can bind to C.
rodentium (Figure 7A). Although it cannot be excluded that the
insoluble Muc2 complex used in this study could contain small
amounts of contamination with other reduction sensitive poly-
meric complexes (for example other mucins), large amounts of
bacteria were found in the secreted Muc2 in C. rodentium infected
animals (Figure 7B–D), consistent with Muc2 binding to C.
rodentium.
Salmonella St Paul, Campylobacter jejuni and Clostridium
difficile induce MUC1 in human distal colon during
infection
Distal colonic biopsies from four patients infected with S. St Paul
or C. jejuni were positive for MUC1, whereas the age, sex and site
matched control samples had no or very little detectable MUC1
(p,0.05, Figure 8A and B). Similarly, the MUC1 expression in
distal colonic biopsies from two IBD patients with acute C. difficile
had higher levels of MUC1 compared to biopsies from the same
site in the absence of C. difficile infection, although low levels of
MUC1 were still present in the IBD control biopsies (Figure 8C).
No MUC1 was demonstrated in one IBD patient infected with
Salmonella enteritidis. Thus, MUC1 is induced in response to
infection by a range of different intestinal pathogens in humans,
in a similar manner to the induction we demonstrated experi-
mentally in C. rodentium infection in mice.
Discussion
This work demonstrates that six mucins have distinctly different
expression patterns throughout the murine intestinal tract,
indicating that they are differentially regulated and are likely to
make different functional contributions to the mucosal barrier.
The cellular content of most mucins changes in response to
infection, with Muc1 being the only mucin to be induced whereas
all other mucins were depleted, albeit to differing degrees. As
mucins are strategically positioned between the vulnerable mucosa
and the bacterial contents of the intestinal lumen [46], the changes
in mucin concentrations and the consequent changes in mucin
binding to bacteria are likely to affect both host-commensal and
host-pathogen interactions.
Muc1/MUC1 appears to play a significant role in host defense
in acute infection. In the murine infection model of C. jejuni, Muc1
is upregulated acutely in the intestine in response to infection [6].
We now show that C. rodentium infection also induces Muc1 in
mouse colon, and similarly that S. St Paul, C. jejuni and C. difficile
induced MUC1 in human colon during infection. Thus, Muc1/
MUC1 is induced in response to infection by a range of different
pathogens in both mice and humans. As Muc1
2/2 mice have a
higher rate of systemic C. jejuni infection [6], Muc1/MUC1
induction appears to be an effective host defense used by both
human and mouse innate immunity. MUC1 expression in biopsies
from inflammatory bowel disease patients with chronic inflamma-
tion was also higher during acute infection compared to the
inflammatory bowel disease control biopsies. This indicates that
MUC1 is upregulated in response to acute infection and that
chronic inflammation by itself is not sufficient to substantially
upregulate MUC1.
Previous studies have shown that mucins bind to several
pathogens [6,22,23] and we show here that mucins bind to C.
rodentium. Increased secretion of mucin in response to infection has
been demonstrated using in vitro airway epithelial cells co-cultured
with Burkholderia cenocepacia and Listeria monocytogenes inoculated rat
ileal loops [47,48]. The depletion in the amount of Alcian blue
positive mucus material as well as Muc2, Muc4, Muc13 and
Muc17 we detected here is also likely to occur as a consequence of
increased secretion and therefore be part of the host defence. In a
recently published study, Muc2 depletion in C. rodentium infected
mice was shown to be dependent on T- and B-cells [49]. However,
for such a host defence to be effective the mucus must be
replenished. In our infected specimens we saw large amounts of
shed whole cells, including goblet cells (Figure 5). The factors
causing premature death of the goblet cells with infection are
unknown, although it appears that C. rodentium directly interact
with and infect murine goblet cells during infection [49] and may
therefore result in goblet cell death. Shedding of these cells would
delay replenishment of the mucus layer providing an advantage to
the mucosal pathogen. In addition, several pathogens have been
shown to specifically inhibit mucin synthesis [50,51]. A further
possibility is that the goblet cells experience endoplasmic reticulum
stress due to the enormous amount of protein synthesis that they
effect during infection and that the consequent unfolded protein
Figure 5. Tissue localization of mucins in the mid large intestine. The apical surface of the mid large intestinal epithelium and crypts are lined
by the cell surface mucins Muc13 and Muc17 as well as a small amount of Muc4 (brown). The goblet cells contain Alcian blue positive material
(blue=highly charged carbohydrate structures, purple=medium charged carbohydrate structures), which mainly is Muc2 (brown) and Muc4. The
photographs were taken using a 206magnification. The quantification scores for Muc1, and Muc13 were significantly different between non-infected
mice (#) and mice infected with C. rodentium for 12 days (N)( *p ,0.05, Mann Whitney U test, n=7). SCL=subcellular localization, RC=region of
crypt. The mucin stains are shown in serial sections on the same tissue area, whereas the mucin stain scores represent the average stain scores for the
entire specimen for each individual mouse.
doi:10.1371/journal.pone.0003952.g005
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severe causes apoptosis [39,52,53]. It seems likely that the host
attempts to remove pathogens by increasing secretion of mucins to
trap and remove pathogens from the epithelial surface, whereas the
pathogen tries to eliminate this host defence by inhibiting the mucin
synthesis and causing shedding of the mucus producing epithelial
cells. Interestingly, goblet cell depletion during infection does not
appear to occur in the respiratory tract where goblet cell hyperplasia
and mucus hypersecretion can continue for extended periods [54].
Furthemore,changesinmucinsecretion islikelyto affecttheresident
microflora due to the large change in glycosylated compounds
available for bacterial degradation [55,56].
In the small intestine and proximal large intestine, C. rodentium
was present, albeit in lower amounts than in the distal large
intestine, and yet there were few signs of mucosal damage,
inflammation or changes in mucins. Furthermore the highest
concentrations of bacteria were detected in the colons of animals
with the highest amount of colonic damage, mucin depletion, and
systemic infection. Even within animals, damage and inflamma-
tion in the distal colon was often patchy suggesting that focal
bacterial penetration of the barrier leads to localised mucin release
and inflammatory responses. Why these bacteria penetrate the
barrier in the distal colon remains to be elucidated but could be
due to an increased bacterial pathogen load in the distal colonic
niche, or an ability to degrade the mucin glycoforms in this region,
and/or involve induction of pathogenicity-related genes in the
bacteria due to local environmental cues. We have demonstrated
that MUC2 is one such cue for C. jejuni which switches on
pathogenicity genes in response to mucin exposure [57]. An IgG
response has been shown to be integral to clearance of C. rodentium
infection [58] and it appears pertinent for our understanding of the
onset of humoral immunity that the C. rodentium specific Ig
production at this stage of infection was restricted to those mice in
which the bacteria had penetrated the mucosal barrier.
C. rodentium infection causes colonic inflammation, mucosal
hyperplasia, epithelial dysfunction in association with increased
permeability to luminal bacteria and a vigorous Th1 inflammatory
response [59]. Thus C. rodentium infection elicits mucosal
inflammation with similarities to inflammatory bowel disease,
and has therefore been used to investigate the relationship between
inflammation and anti-bacterial immunity in the gut [4].
MUC5AC, which is a product of normal gastric mucosa, is absent
from normal colon but frequently present in colorectal adenomas
and colon cancers [60,61], and expressed in patients with
Figure 6. Tissue localization of mucins in the distal large intestine. The apical surface of the distal large intestinal epithelium and crypts are
lined by the cell surface mucins Muc13 and Muc17 as well as a small amount of Muc4 (brown). The goblet cells contain Alcian blue positive material
(blue=highly charged carbohydrate structures, purple=medium charged carbohydrate structures), which mainly is Muc2 (brown), although the
goblet cells of the surface also contain Muc4. The photographs were taken using a 206magnification. The quantification scores for Alcian blue,
Muc1, Muc13 and Muc17 were significantly different between non-infected mice (#) and mice infected with C. rodentium for 12 days (N)( *p ,0.05,
Mann Whitney U test, n=7). SCL=subcellular localization, RC=region of crypt. The mucin stains are shown in serial sections on the same tissue area,
whereas the mucin stain scores represent the average stain scores for the entire specimen for each individual mouse.
doi:10.1371/journal.pone.0003952.g006
Figure 7. C. rodentium binding to Muc2. ELISA plates were coated with the ‘‘insoluble’’ Muc2 complex or with BSA and incubated with
biotinylated C. rodentium. Statistics: Mean6SD, *** p,0.001 (t-test, n=6) (A). Large amounts of bacteria can be found entangled in the secreted Muc2
in C. rodentium infected animals (B–D). By brightfield observation using a 206lens (B) the Muc2 is visualized as a brown stain, and the presence of
large amounts of bacteria within the secreted Muc2 can be seen by reflected light Nomarski differential interference observation (C; 406lens and D;
1006lens).
doi:10.1371/journal.pone.0003952.g007
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mice in our study, suggesting that induction of MUC5AC may
arise from more long term effects of chronic inflammation.
However, similar to our findings in murine C. rodentium infection, a
reduction in MUC2 expression occurs in UC adjacent to
ulceration and in active colitis [62,63], and MUC1 expression
was upregulated in severe UC at the site of rupture of crypt
abscesses [63]. Our non-infected human biopsies from IBD
patients only had a very low amount of MUC1, but they did
not contain any crypt abscesses, which may induce MUC1 in a
similar manner to acute infection.
In conclusion, in response to intestinal infection mucin secretion
is increased and most mucins are depleted from the epithelium
whilst MUC1 is upregulated. As mucins bind pathogens,
increasing the secretion of mucins is likely to aid the host by
trapping and removing pathogens from the epithelial surface.
Pathogens may subvert this host defence by inhibiting mucin
synthesis and secretion or causing premature shedding of the
mucus producing epithelial cells. Further exploration of the
dynamic host mucin – bacterial interactions that occur in the
mucin covered mucosal interface will increase our understanding
of human susceptibility to infection.
Supporting Information
Table S1 Histological scoring of murine colitis.
Found at: doi:10.1371/journal.pone.0003952.s001 (0.03 MB
DOC)
Figure S1 Mild PAS staining with and without prior saponifi-
cation on a non-infected and C. rodentium infected mouse.
Found at: doi:10.1371/journal.pone.0003952.s002 (7.16 MB TIF)
Figure S2 Expression of Muc1 in the distal large intestine is
upregulated in response to infection with C. rodentium. Repre-
sentative examples of Muc1 expression determined by immuno-
histochemistry in the distal colon of mice infected with C.
rodentium for 12 days and non-infected mice. The photographs
were taken using 206magnification.
Found at: doi:10.1371/journal.pone.0003952.s003 (26.10 MB
TIF)
Figure 8. Induction of MUC1 in human intestinal infection. MUC1 expression in distal colon in humans with S. St Paul (upper left panel) and C.
jejuni (3 upper right panels) gastroenteritis (A). The lower panels show lack of MUC1 in non-infected age, sex and colonic site matched controls. The
MUC1 quantification scores (B) were higher in colonic biopsies from infected (N) than non-infected (#) patients (* p,0.05, Mann Whitney U test,
n=8). Colonic biopsies from two IBD patients with acute C. difficile infection demonstrated that MUC1 is higher during infection even in the
background of chronic inflammation. The photographs were taken using 206magnification.
doi:10.1371/journal.pone.0003952.g008
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